vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vakcíny - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 a 5. 1 in product information document). použití této vakcíny musí být v souladu s oficiálními doporučeními.
enjaymo
sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - imunosupresiva - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulární blokáda - všechny ostatní terapeutické přípravky - zvrat neuromuskulární blokády vyvolané rocuroniem nebo vekuroniem. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - jiné léky pro žluči terapie - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vakcíny - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
aminoplasmal b.braun 10% infuzní roztok
b. braun melsungen ag, melsungen array - 790 isoleucin; 829 leucin; 4566 lysin-acetÁt; 13214 monohydrÁt lysinu; 2445 methionin; 1117 fenylalanin; 1459 threonin; 1503 tryptofan; 1514 valin; 96 arginin; 717 histidin; 27 alanin; 55 glycin; 103 kyselina asparagovÁ; 665 kyselina glutamovÁ; 4147 prolin; 4717 serin; 1507 tyrosin - infuzní roztok - aminokyseliny
aminoplasmal b.braun 5% e infuzní roztok
b. braun melsungen ag, melsungen array - 790 isoleucin; 829 leucin; 851 lysin-hydrochlorid; 2445 methionin; 1117 fenylalanin; 1459 threonin; 1503 tryptofan; 1514 valin; 96 arginin; 717 histidin; 27 alanin; 55 glycin; 103 kyselina asparagovÁ; 665 kyselina glutamovÁ; 4147 prolin; 4717 serin; 1507 tyrosin; 1306 trihydrÁt natrium-acetÁtu; 2458 hydroxid sodnÝ; 1170 kalium-acetÁt; 1322 chlorid sodnÝ; 856 hexahydrÁt chloridu hoŘeČnatÉho; 1341 dodekahydrÁt hydrogenfosforeČnanu sodnÉho - infuzní roztok - roztoky pro parenterÁlnÍ vÝŽivu, kombinace
betesil 2,25mg léčivá náplast
ibsa slovakia s.r.o., bratislava array - 167 betamethason-valerÁt - léčivá náplast - 2,25mg - betamethason
octenisept 1mg/g+20mg/g kožní roztok
schülke & mayr gmbh, norderstedt array - 15987 oktenidin-dihydrochlorid; 3572 fenoxyethanol - kožní roztok - 1mg/g+20mg/g - oktenidin, kombinace
camzyos
bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - ostatní srdeční přípravky - treatment of symptomatic obstructive hypertrophic cardiomyopathy.